We are live on ! Find out more
NERM

New England Research & Management Portfolio holdings

AUM $257M
1-Year Est. Return 25.66%
This Fund
S&P 500
This Quarter Est. Return
+10.74%
1 Year Est. Return
+25.66%
3 Year Est. Return
+56.38%
5 Year Est. Return
+58.71%
10 Year Est. Return
+176.32%
AUM
$189M
AUM Growth
+$13.3M
Cap. Flow
-$3.27M
Cap. Flow %
-1.73%
Top 10 Hldgs %
24.14%
Holding
169
New
20
Increased
29
Reduced
82
Closed
14

Top Buys

Rank Stock Value
1
J icon
Jacobs Solutions
J
+$3M
2
APD icon
Air Products & Chemicals
APD
+$2.21M
3
ORCL icon
Oracle
ORCL
+$1.67M
4
TER icon
Teradyne
TER
+$1.12M
5
PH icon
Parker-Hannifin
PH
+$953K

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$1.82M
2
AMZN icon
Amazon
AMZN
+$1.48M
3
AVGO icon
Broadcom
AVGO
+$1.19M
4
AMGN icon
Amgen
AMGN
+$1.13M
5
SBUX icon
Starbucks
SBUX
+$1.01M

Sector Composition

Rank Sector Weight
1 Industrials 21.74%
2 Healthcare 18.33%
3 Technology 16.98%
4 Consumer Staples 11.96%
5 Consumer Discretionary 9.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MMM icon
126
3M
MMM
$84.9B
$374K 0.2%
4,090
– –
DXCM icon
127
DexCom
DXCM
$32.6B
$366K 0.19%
+2,950
New +$301K
NOC icon
128
Northrop Grumman
NOC
$75.5B
$364K 0.19%
777
-1,520
-66% -$712K
INTU icon
129
Intuit
INTU
$88B
$359K 0.19%
575
– –
CARR icon
130
Carrier Global
CARR
$45.8B
$358K 0.19%
6,225
-13,403
-68% -$709K
ULTA icon
131
Ulta Beauty
ULTA
$23.3B
$355K 0.19%
+725
New +$306K
IBP icon
132
Installed Building Products
IBP
$5.31B
$352K 0.19%
1,925
– –
BLK icon
133
Blackrock
BLK
$164B
$345K 0.18%
+425
New +$297K
ROK icon
134
Rockwell Automation
ROK
$46.3B
$331K 0.18%
+1,065
New +$298K
AB icon
135
AllianceBernstein
AB
$3.36B
$327K 0.17%
+10,550
New +$310K
PNR icon
136
Pentair
PNR
$9.03B
$320K 0.17%
+4,400
New +$284K
XYL icon
137
Xylem
XYL
$25.1B
$314K 0.17%
2,744
– –
CMCSA icon
138
Comcast
CMCSA
$86.7B
$303K 0.16%
6,900
– –
SNPS icon
139
Synopsys
SNPS
$70.5B
$283K 0.15%
+550
New +$281K
ALL icon
140
Allstate
ALL
$65B
$280K 0.15%
2,000
– –
TRN icon
141
Trinity Industries
TRN
$2.24B
$273K 0.14%
10,250
– –
NVS icon
142
Novartis
NVS
$263B
$272K 0.14%
2,695
– –
DAR icon
143
Darling Ingredients
DAR
$10.5B
$269K 0.14%
5,400
-50
-0.9% -$2.27K
OGN icon
144
Organon & Co
OGN
$3.59B
$267K 0.14%
18,521
-405
-2% -$5.51K
EQNR icon
145
Equinor
EQNR
$109B
$266K 0.14%
8,395
– –
NEM icon
146
Newmont
NEM
$131B
$266K 0.14%
6,425
-1,100
-15% -$42.5K
KEYS icon
147
Keysight
KEYS
$53.3B
$262K 0.14%
1,650
-1,900
-54% -$258K
DRI icon
148
Darden Restaurants
DRI
$23.7B
$261K 0.14%
1,591
– –
SLB icon
149
SLB Ltd
SLB
$80.4B
$249K 0.13%
4,792
– –
ENB icon
150
Enbridge
ENB
$106B
$221K 0.12%
6,125
– –
3 4 5
6
7

Similar funds

GFP
Guardian Financial Partners Orange, California $257M AUM 19.03% 1-Year Est. Return
UI
Untitled Investments New York $257M AUM 15.31% 1-Year Est. Return
HWA
HMV Wealth Advisors Shreveport, Louisiana $257M AUM 26.62% 1-Year Est. Return
LGW
Leslie Global Wealth Itasca, Illinois $257M AUM 23.12% 1-Year Est. Return
TCG
Transcendent Capital Group Edmond, Oklahoma $257M AUM 25.68% 1-Year Est. Return
6F
626 Financial Portage, Michigan $257M AUM 22.23% 1-Year Est. Return
MCP
Miller Capital Partners Troy, Michigan $257M AUM
BWM
Birchcreek Wealth Management Miami Township, Ohio $257M AUM 34.72% 1-Year Est. Return

New England Research & Management's Q4 2023 Portfolio in Review

As of Q4 2023, New England Research & Management held 169 positions worth $189M, up 7.6% from $175M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

New England Research & Management's Q4 2023 filing shows 20 new, 29 increased, 82 reduced and 14 closed positions. Its largest new stake was Jacobs Solutions: 27,534 shares worth $2.96M. The largest sale was UnitedHealth, an estimated $1.82M.

By sector, the portfolio is most concentrated in Industrials at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Technology.

  • New England Research & Management's largest Q4 2023 buy was Jacobs Solutions: 27,534 shares worth $2.96M.
  • New England Research & Management added most to Oracle in Q4 2023, an estimated $1.67M increase.
  • New England Research & Management's biggest Q4 2023 reduction was UnitedHealth, cutting an estimated $1.82M.
  • New England Research & Management fully exited Broadcom in Q4 2023, selling an estimated $1.19M.
  • New England Research & Management's ten largest holdings make up 24% of its $189M portfolio in Q4 2023.
  • New England Research & Management opened 20 new positions and closed 14 in Q4 2023.
  • New England Research & Management's portfolio value rose 7.6% quarter-over-quarter to $189M.

Based on New England Research & Management's 13F filing for Q4 2023, filed 6 Feb 2024.